INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Oral beta-glucan failed to alter innate immune responses in healthy men.

A randomized open-label pilot trial evaluated 15 healthy male volunteers assigned to 1,000 mg of oral beta-glucan daily (n = 10) or control (n = 5) for 7 days. Serum beta-glucan concentrations were barely detectable in participants across all time points. Ingestion of oral beta-glucan did not affect leukocyte cytokine production or microbicidal activity.

Study type
Randomized open-label trial
Who was studied
15 healthy male volunteers
What was measured
Serum beta-glucan levels, cytokine production, and microbicidal activity

THE PAPER

The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study.

Leentjens J, Quintin J, Gerretsen J, Kox M, Pickkers P, Netea MG. PLoS One, 2014.

PubMed 25268806 ↗DOI 10.1371/journal.pone.0108794 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.